Annelore Cortoos

651 total citations
14 papers, 94 citations indexed

About

Annelore Cortoos is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Annelore Cortoos has authored 14 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 5 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Annelore Cortoos's work include Multiple Myeloma Research and Treatments (10 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Protein Degradation and Inhibitors (4 papers). Annelore Cortoos is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Protein Degradation and Inhibitors (4 papers). Annelore Cortoos collaborates with scholars based in United States, Malaysia and Lebanon. Annelore Cortoos's co-authors include Silverio Perrotta, Antonis Kattamis, Vicky Huang, Marine Weill, John B. Porter, Raffaella Origa, Alì Taher, Alexandra Kourakli, Shaji Kumar and Daan Dierickx and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Annelore Cortoos

11 papers receiving 93 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annelore Cortoos United States 5 86 70 18 15 13 14 94
Liesl Mathias United Kingdom 3 52 0.6× 59 0.8× 12 0.7× 9 0.6× 21 1.6× 3 82
Laura Frogheri Italy 7 59 0.7× 66 0.9× 16 0.9× 13 0.9× 11 0.8× 13 82
Wilma Deplano Italy 5 54 0.6× 18 0.3× 9 0.5× 18 1.2× 16 1.2× 5 76
Tatiana Zinger Lebanon 6 74 0.9× 88 1.3× 6 0.3× 6 0.4× 18 1.4× 7 112
Anna Maria Scattolin Italy 5 44 0.5× 17 0.2× 11 0.6× 20 1.3× 9 0.7× 10 66
Giovanni Pisapia Italy 5 40 0.5× 14 0.2× 6 0.3× 12 0.8× 9 0.7× 6 62
Carla Araujo France 5 32 0.4× 12 0.2× 4 0.2× 36 2.4× 27 2.1× 8 58
Sophie Dimicoli‐Salazar France 5 43 0.5× 19 0.3× 4 0.2× 4 0.3× 13 1.0× 11 57
Sameer Mahesh United States 3 37 0.4× 29 0.4× 3 0.2× 7 0.5× 14 1.1× 5 60
Aimee Jackson United Kingdom 5 41 0.5× 31 0.4× 3 0.2× 17 1.1× 22 1.7× 14 85

Countries citing papers authored by Annelore Cortoos

Since Specialization
Citations

This map shows the geographic impact of Annelore Cortoos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annelore Cortoos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annelore Cortoos more than expected).

Fields of papers citing papers by Annelore Cortoos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annelore Cortoos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annelore Cortoos. The network helps show where Annelore Cortoos may publish in the future.

Co-authorship network of co-authors of Annelore Cortoos

This figure shows the co-authorship network connecting the top 25 collaborators of Annelore Cortoos. A scholar is included among the top collaborators of Annelore Cortoos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annelore Cortoos. Annelore Cortoos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Nooka, Ajay K., Jonathan L. Kaufman, César A. Rodríguez, et al.. (2024). Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study. British Journal of Haematology. 204(6). 2227–2232.
3.
4.
5.
Ailawadhi, Sikander, Sarah M. Larson, Shannon Ferrante, et al.. (2024). Characteristics, Treatment Patterns, and Outcomes of Patients with Multiple Myeloma Retreated with Daratumumab in Real-World Clinical Practice in the USA. Blood. 144(Supplement 1). 2381–2381.
6.
Gordan, Lucio, et al.. (2024). MM-318 Perspectives of Single-Center Community Hematologists/Oncologists on Minimal Residual Disease Testing Among Patients With Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 24. S546–S546. 1 indexed citations
7.
8.
9.
Jakubowiak, Andrzej, Shaji Kumar, Huiling Pei, et al.. (2022). Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma. The Oncologist. 27(7). e589–e596. 12 indexed citations
10.
Rodriguez, Cesar, Jonathan L. Kaufman, Jacob P. Laubach, et al.. (2022). Daratumumab (DARA) + lenalidomide, bortezomib, and dexamethasone (RVd) in transplant-eligible newly diagnosed multiple myeloma (NDMM): A post hoc analysis of sustained minimal residual disease (MRD) negativity from GRIFFIN.. Journal of Clinical Oncology. 40(16_suppl). 8011–8011. 4 indexed citations
11.
Taher, Alì, Raffaella Origa, Silverio Perrotta, et al.. (2017). New film‐coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower‐risk MDS: Results of the randomized, phase II ECLIPSE study. American Journal of Hematology. 92(5). 420–428. 59 indexed citations
12.
Taher, Alì, Raffaella Origa, Silverio Perrotta, et al.. (2016). New Film-Coated Tablet Formulation of Deferasirox Is Well Tolerated in Patients with Thalassemia or MDS: Results of the Randomized, Phase II E.C.L.I.P.S.E. Study. Blood. 128(22). 1285–1285. 4 indexed citations
13.
Taher, Alì, Raffaella Origa, Silverio Perrotta, et al.. (2016). Improved Patient-Reported Outcomes with a Film-Coated Versus Dispersible Tablet Formulation of Deferasirox: Results from the Randomized, Phase II E.C.L.I.P.S.E. Study. Blood. 128(22). 850–850. 6 indexed citations
14.
Dierickx, Daan, Annelore Cortoos, & Steven Vanderschueren. (2012). The haemophagocytic syndrome.. PubMed. 66(6). 448–52. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liesl Mathias Breakdown of academic impact, for papers by Laura Frogheri Breakdown of academic impact, for papers by Wilma Deplano Breakdown of academic impact, for papers by Tatiana Zinger Breakdown of academic impact, for papers by Anna Maria Scattolin Breakdown of academic impact, for papers by Giovanni Pisapia Breakdown of academic impact, for papers by Carla Araujo Breakdown of academic impact, for papers by Sophie Dimicoli‐Salazar Breakdown of academic impact, for papers by Sameer Mahesh Breakdown of academic impact, for papers by Aimee Jackson
Rankless by CCL
2026